Current pharmacological treatments for bronchiolitis are useless. The case for the con's

Paediatric Respiratory Reviews

Volumn 7, Issue SUPPL. 1, 2006, Pages

  Landau, Louis I ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

asthma; bronchiolitis; pharmacological measures; treatment

Indexed keywords

ADRENALIN; ANTIBIOTIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CETIRIZINE; CORTICOSTEROID; DEOXYRIBONUCLEASE; GLUCOCORTICOID; IMMUNOGLOBULIN; INTERFERON; IPRATROPIUM BROMIDE; MONTELUKAST; OXYGEN; PALIVIZUMAB; PLACEBO; RETINOL; RIBAVIRIN; SURFACTANT;

ADENOVIRUS; ARTICLE; ASTHMA; BRONCHIOLITIS; CHILD CARE; CHLAMYDIA; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; HUMAN; IMMUNE RESPONSE; INFLUENZA VIRUS; MEDICAL DECISION MAKING; OXYGEN THERAPY; PARAINFLUENZA VIRUS; PATIENT SELECTION; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RHINOVIRUS; SOCIAL STATUS; TREATMENT FAILURE; TREATMENT OUTCOME; VIRUS INFECTION; WHEEZING;

EID: 33745184680     PISSN: 15260542     EISSN: 15260550     Source Type: Journal    
DOI: 10.1016/j.prrv.2006.04.161     Document Type: Note

References (17)

1. Welliver R.C., and Duffy L. The relationship of RSV specific immunoglobulin IgE antibody responses in infancy, recurrent wheezing and pulmonary function at 7-8 years. Pediatr Pulmonology 15 (1993) 19-27
2. Fitzgerald D.A., and Killam H.A. Bronchiolitis: Assessment and Evidence Based Management. Med J Aust 180 (2004) 399-404
3. Kellner J.D., Ohllson A., Gadomski A.M., and Wang E.E. Bronchodilators for bronchiolitis. Cochrane Review (2003)
4. Sanchez I., Vizcaya C., Garcia D., and Campos E. Response to bronchodilator in infants with bronchiolitis can be predicted from wheeze patterns. Respirology 10 (2005) 603-608
5. Wainright C.E., Altamirano L., Cheney M., et al. A multicentre randomized double blind controlled trial of nebulized epinephrine in infants with acute bronchiolitis. N Engl J Med 349 (2003) 27-35
6. Numa A., Williams G.D., and Dakin C. Effect of nebulized epinephrine on respiratory mechanics and gas exchange in bronchiolitis. Am J Resp Crit Care Med 164 (2001) 86-91
7. Hartling L., Wiebe N., Russell K., Patel H., and Klassen P.T. Epinephrine for bronchiolitis. Cochrane Database of Systematic Reviews (2005)
8. Wang E.E.L., Milner R., Allen U., and Maj H. Bronchodilators for treatment of mild bronchiolitis: a factorial randomized trial. Arch Dis Child 67 (1992) 289-293
9. Garrison M.M., Christiakis D.A., Harvey E., et al. Systemic corticosteroids in infant bronchiolitis: a meta analysis. Pediatrics 105 (2000) E44
10. Schuh S., Coates A.L., Binnie R., et al. Efficacy of oral dexamethasone in outpatients with acute bronchiolitis. J Pediatr 140 (2002) 27-32
11. Randolph A.G., and Wang E.E.L. Ribavirin for respiratory syncitial virus infection of the lower respiratory tract. The Cochrane Library (2003)
12. Lozano J.M., and Wang E. Bronchiolitis. Clin Evid 8 (2002) 291-303
13. Reduction of respiratory syncitial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncitial virus immune globulin prophylaxis. The PREVENT study group. Pediatrics 99 (1997) 93-99
14. Palivizumab, a humanized respiratory syncitial virus monoclonal antibody, reduces hospitalization from respiratory syncitial virus infection in high risk infants. The IMpact RSV study group. Pediatrics 102 (1998) 531-537
15. HarkenseeC, Brodlie M., Embleton N.D., and McKean M. Passive immunization of preterm infants with palivizumab against RSV infection. J Infection 52 (2006) 2-8
16. Bisgaard H. Montelukast in RSV bronchiolitis. Am J Resp Crit Care Med 169 (2003) 542-543
17. Curran M.P., Scott L.J., and Perry C.M. Cetirizine:a revierw of its use in allergic diseases. Drugs 64 (2004) 503-561